Plasma homocysteine and methylenetetrahydrofolate reductase gene polymorphism in human health and disease: An update

International Journal of Human Genetics

Volumn 8, Issue 1-2, 2008, Pages 171-179

  Vinukonda, Govindaiah ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Coronary artery disease (CAD); Coronary heart disease (CHD); Genetic polymorphism; Genotype; Homocysteine; Methylene tetrahydrofolate (MTHFR); Myocardial infractions (MI)

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ARTERY DISEASE; CARDIOVASCULAR DISEASE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; GENE MUTATION; GENETIC POLYMORPHISM; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMOBILIZATION; INDIA; JAPAN; LIPID DIET; NETHERLANDS; REVIEW; SMOKING; STROKE;

EID: 67349085526     PISSN: 09723757     EISSN: None     Source Type: Journal    
DOI: 10.1080/09723757.2008.11886029     Document Type: Review

References (46)

1. Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ 1996. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk for myocardial infraction. Q J Med, 89(6): 437-444.
2. Alfthan G, Pekkanen J, Jauhiainen M et al. 1994. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis, 106: 9-19
3. Anderson JL, King G.J, Thomson MJ et al. 1997. A mutation in the Methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol, 30(5): 1206-1211.
4. Araki Atsushi, Sako Yoshiyasu 1987. Determination of free and total homocysteine inhuman plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography, 422: 43-52.
5. Arnensen E, Refsum H, Bonna KH, Ueland PM, Forde OH, Nordrehaug JE 1995. Serum total homocysteine and coronary heart disease. Int J Edemiol, 24: 1924-1930.
6. Bonaa KH, Njolstad I, Ueland PM, Schirmer H et al. 2006. Homocysteine lowering and cardiovascular events after acute myocardial infraction. N Eng J Med, 354: 1578-1588.
7. Chacko KA 1998. Plasma Homocysteine levels in patients with coronary heart disease. Indian Heart Journal, 50(3): 295-299.
8. Emmanouil S Brilakis, Peter B Berger, Karla V Ballman, Rima Rozen 2003. Methylenetetrahydrofolate reductase (MTHFR) 677 C>T and methionine synthase reductase (MTRR) 66A>G polymorphism: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid. Atherosclerosis, 168: 315-322.
9. Gallagher PM, Meleady R, Shields DC et al.1996. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation, 94(9): 2154-2158
10. Gardemann A, Weidemann H, Philipp M et al. 1999. The TT genotype of the methylenetetrahydrofo late reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. Eur Heart J, 20(8): 584-592.
11. George N Welch, Joseph loscalzo 1998. Homocysteine and Atherothromobosis. The New Eng Journal of Medicine, 338(15): 1042-1050.
12. Girelli BD, Friso S, Trabetti E, Oliveri O, et al 1998. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and Folate in subjects from Northern Italy with or without angiographically documented severe coronary atherosclerotic Disease: Evidence for an important genetic-environmental interaction. Blood, 91(11): 4158-4163.
13. Graham IM, Daly LE, Refsum H et al. 1997. Plasma homocysteine as a risk factor for vascular disease: the European concerted action project. JAMA, 277: 1775-1771.
14. Harry H Yu, Rana Joubran, Muhammad Asmi, Terence Law, Nader Rifai 2000. Agreement among four homocysteine assays and results in-patients with coronary atherosclerosis and controls. Clinical Chemistry, 46(2): 258-264
15. Hong SH, Song J, Kim JQ 2001, Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7. Mol Cell Probes, 15(2): 119-123
16. Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shiroki H, Kinoshita M 1996. Molecular variant of 5, 10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis, 121(2): 293-294.
17. Kalita J, Srivastava R, Bansal V, Agarwal S, Misra UK 2006. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients. Neurology India, 54(3): 260-264.
18. Kang SS, Wong PW, Malinow MR 1992. Hyperhomocysteinemia as a risk factor for Occlusive vascular disease. Ann.Rev Nutr, 12: 279-298.
19. Kim CH, Hwang KY, Choi TM, Shin WY, Hong SY 2001. The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary artery disease. Int J Cardiol, 78(1): 13-17
20. Kluijtmans LA, Boers GH, Frost P et al. 1996. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet, 58(1): 35-41.
21. Kluijtmans LA, Kastelein JJ, Lindemans J et al. 1997, Thermolabile methylenetetra hydrofolate reductase in coronary artery disease. Circulation, 96(8): 2573-2577.
22. Kumar J et al. 2005. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J. Human Genetics, 50: 655-663
23. Mc Cully KS 1969. Vascular pathology in hyperhomocystenemia: Implications for the pathogenesis of Arteriosclerosis. Am J Pathology, 56: 111-128.
24. Meisel C, Cascorbi I, Gerloff T et al. 2001. Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease. Atherosclerosis, 154(3): 651-658.
25. Misra A et al. 2002. Hyperhomocysteinemia and low intakes of folic acid and vitamin B12 in urban North India. E J Nutrition, 41: 68-77
26. Morita H, Taguchi J, Kurihara H, et al.1997. Genetic polymorphism of 5,10-methylene-tetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation, 95(8): 2032-2036.
27. Naushad SM, Md Nurul Jain Jamal, R. Angalena, C. Krishna Prasad , A. Radha Rama Devi 2007. Hyperhomocysteinemia and the compound heterozygous state for methylene tetra- hydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians. Blood Coagulation and Fibrinolysis, 18:113-117
28. Nygard O, Nondrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. 1997. Plasma homocysteine levels and mortality in patients with Coronary artery disease. N Engl J Med, 337: 230-236.
29. Ou T, Yamakawa-Kobayashi, Arinami T. et al. 1998, Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case - control study. Atherosclerosis, 137(1): 23-28.
30. Pandey SN, Vaidya AD, Vaidya RA, Talwalkar S 2006. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women. Determinants and directionality. J Assoc Physician India, 54: 769-774.
31. Patel JV et al. 2006. Impact of migration on coronary heart disease risk factor: comparison of Gujaratis in Britain and their contemporaries in Indian villages. Atherosclerosis, 186: 297-306
32. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG 1995. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet, 346: 1395-1398.
33. Refsum H, Chittaranjan SY, Milind G et al. 2001. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. A J Clinical Nutrition, 74: 233-241.
34. Refsum H 2006. "Hordaland homocysteine study: a community based study of homocysteine, its determinants, and association with disease". Journal of Nutrition, 136 (6) suppl: 1731S-1740S
35. Reinhardt D, Sigusch HH, Vogt SF, Farker K, Muller S, Hoffmann A 1998. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease. Eur J Clin Invest, 28(1): 20-23.
36. Sazci A, Emel Ergul, Tuncer N, Akpinar G, Kara I 2006. Methylenetetrahydrofolate reductase gene Polymorphism are associated with ischemic and hemorrhagic stroke: Dual effect or MTHFR polymorphism C677T and A1298C. Brain Research Bulletin, 71: 45-50.
37. Stampfer MJ, Malinow MR, Willett WC et al. 1992. A Prospective study of homocysteine and risk of homocysteine myocardial infraction in US physicians. JAMA, 268: 877-881.
38. Stehouwercoen DA, Matty PW, Berg MV, Jakobs C, Feskens EJM, Kromhout D 1998. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men a 10 year follow up. Arterioscler Thromb Vasc Biol, 18: 1895-1901
39. Tanis BC, Blom HJ, Bloemenkamp DGM, et al 2004. Folat, Homocysteine levels methylenetetrahydrofolate reductase (MTHFR) 677C-T variant, and the risk of myocardial infraction in young women: Effect of female hormones on homocysteine level. Journal of Thrombosis and Haemostastisis, 2: 35-41.
40. Sirachainan N, Tapanapruksakul P, Visudtibham A, Chuansumrit A et al 2006. Homocysteine, MTHFR C677T, Vit B12, and Folate levels in Thai Children with ischemic stroke: A Case-Control study, J Pediatr Hematol Oncol, 28: 803-808.
41. Taylor LM Jr, De Frang RD, Harris EJ Jr, Porter JM 1991. The association of elevated plasma homocysteine with progression of symptomatic peripheral arterial disease. J Vasc Surg, 13: 128-130
42. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ 1994. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke, 25: 1924-1930.
43. Vollset SE, Refsum H, Irgens LM et al. 2000. Plasma total homocysteine, pregnancy Complications and adverse pregnancy out come: The hordaland homocysteine study. Am J clinical Nutr, 71: 962-968.
44. Wolfgang Herrmann 2001. The importance of Hyperhomocystenemia as a Risk factor for diseases: An Overview. Clin Chem Lab Med, 39(8): 666-674.
45. Yoo JH, Park JE, Hong K, Lee S, Kim DK, Lee WR, Park SC 1999. Moderate hyperhomocysteinemia is associated with the presence of Coronary artery disease and the severity of Coronary Atherosclerosis in Koreans. Thrombosis Research, 94: 45-52
46. Zee Robert YL, Mora S, Cheng S, Erlich H, Lindpaintner, Rifai N, Buring J, Ridker P 2007. Homocysteine, 5, 10, Methylenetetrahydrofolate Reductase 677 C-T polymorphism, Nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clinical Chemistry, 53(5): 1-7